Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "erbitux"

BMS agrees to transfer Erbitux's North American business to Lilly
Pharma Letter

ELI LILLY : Lilly, Bristol-Myers Squibb Update Erbitux (cetuxi...

Eli Lilly and Company and Bristol-Myers Squibb Company recently reported that the companies have agreed to transfer rights to Erbitux (cetuximab) in North America , including the U.S., Canada , and Puerto Rico , from Bristol-Myers Squibb to Lilly. ... 4 Traders, 4 weeks ago
[x]  

1 images for "erbitux"

Pharma Letter, 1 month ago

Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux

(M2) Market Research Reports, Inc. has announced the addition of " " research report to their website http://www.MarketResearchReports.com
 Individual.com1 month ago Research and Markets: Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux  Yahoo! UK and Ireland1 month ago RESEARCH AND MARKETS : Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux  4 Traders1 month ago Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) 2013 - 2020  Fat Pitch Financials1 week ago
[x]  
Jutia Group

Bristol-Myers Squibb Company announces transfer of full commercialisation rights to Eli Lilly and Company for Erbitux (cetuximab)

Biopharmaceutical products company Bristol-Myers Squibb Company (NYSE:BMY) declared on Thursday an agreement to transfer the rights to Erbitux (cetuximab) in North America, including the US, Canada and Puerto Rico, to Eli Lilly and Company ...
 Individual.com1 month ago Company Update: Bristol-Myers Squibb Company (NYSE:BMY) Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer  Jutia Group1 day ago Market Update (NYSE:BMY): Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen  Jutia Group1 week ago Merck KGaA (MKGAY) Management on Q1 2015 Results - Earnings Call Transcript  Seeking Alpha1 week ago
[x]  

Bristol-Myers to Transfer Certain Erbitux Rights to Eli Lilly - Analyst Blog

Bristol-Myers Squibb Company BMY announced its intention to transfer its rights to the oncology drug, Erbitux, in North America, including the U.S., Canada, and Puerto Rico to Eli Lilly and Company LLY . The rights include full commercialization ...
 Zacks.com1 month ago

Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY) 4/16/2015

April 16, 2015 By Riley McDermid , BioSpace.com Breaking News Sr. Editor After a 14-year marriage, Bristol-Myers Squibb Company said Thursday that it will transfer the North American rights to cancer drug Erbitux (cetuximab) to partner Eli ...
 ClinicSpace1 month ago Eli Lilly Snags North American Rights to Erbitux From Bristol-Myers Squibb  BioSpace1 month ago

Forum Post: Chinese Lingzhi mushrooms as a supplement to Erbitux

my dad has larynx tumour and is going to be treated with Erbitux/Cetuximab +Radio. My sister and me we are very anxious about side effects of this treatment and we are thinking of different ways how it might be possible to support his body and make ...
 Macmillan Cancer Support2 months ago Forum Post: RE: Chinese Lingzhi mushrooms as a supplement to Erbitux  Macmillan Cancer Support2 months ago

REXAHN PHARMACEUTICALS, INC. : Strong Data on Rexahn's Non-Toxic Targeted Therapy Revealed at Top Cancer Meetings

/ Rexahn Pharmaceuticals, Inc. (NYSE: RNN) took a big step toward greater US and international attention for its novel drugs in development when it presented new data on Supinoxin (RX-5902) and RX-3117 at the widely-attended 2015 American ...
 4 Traders19 hours ago Strong Data on Rexahn's Non-Toxic Targeted Therapy Revealed at Top Cancer Meetings  Individual.com10 hours ago

KaloBios Appoints Ronald A. Martell Executive Chairman

/PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Ronald A. Martell, to the position of Executive Chairman. Mr. Martell currently serves as a member of the KaloBios Board of Directors. In this new role, ...
 TickerTech.com12 hours ago KALOBIOS PHARMACEUTICALS : Appoints Ronald A. Martell Executive Chairman  4 Traders12 hours ago KaloBios Pharmaceuticals, Inc. (KBIO) Elects Ronald A. Martell To Board Of Directors  FierceBiotech1 month ago KaloBios Pharmaceuticals, Inc. Elects To Board Of Directors  BioSpace1 month ago
[x]  
Creative Times

Global Colorectal Cancer Therapeutics Market 2020 - Industry Survey, Market Size, Competitive Trends

The report provides an estimation of the market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth pipeline analysis, and deal analysis. The CRC ...
 Individual.com19 hours ago Colorectal Cancer Therapeutics Market Will Be CAGR of 1.8% to $9.4 billion by 2020: Radiant Insights, Inc  Individual.com3 weeks ago Radiant Insights: Colorectal Cancer Therapeutics Market 2019: Latest Industry Analysis Presented By Radiant Insights  BusinessWeek1 month ago Colorectal cancer treatment market forecast to be worth US$9.4Bn by 2020  TransWorldNews1 month ago
[x]  

KRAS Mutation Test for Colorectal Cancer Diagnosis Approved

The cobas KRAS mutation real-time polymerase chain reaction test (Photo courtesy of Roche Diagnostics) Please add personal message for the request Please, fill the area above A real-time polymerase chain reaction test has been designed to ...
 Lab Medica1 day ago 5/26/15 - Roche Receives FDA Approval for cobasĀ® KRAS Mutation Test  Pharmacy Choice2 days ago Roche receives FDA approval for colorectal cancer diagnostic test  Individual.com1 day ago FDA Approves Roche's KRAS Mutation Test  G2 Intelligence1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less